Stocks
Amgen Stock Sees Heavy Trading Amid Record High Valuation
Ieq Capital LLC decreased its stake in Amgen Inc., NASDAQ: AMGN, by 47.3% in the second quarter, according to a recent Form 13F filing with the Securities & Exchange Commission.
The fund owned 14,567 shares of the medical research company's stock after selling 13,072 shares during the quarter, which is worth $5,275,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of Amgen, including Vanguard Group Inc., BlackRock Inc., State Street Corp, Capital World Investors, and Geode Capital Management LLC.